Wirk, B.; Lim, J. Ruxolitinib Is an Effective Therapy for Ciltacabtagene Autoleucel-Associated Parkinsonism in Multiple Myeloma. J Hematol 2025, 14 (3), 146-151. https://doi.org/10.14740/jh2046.